Kraig Biocraft Laboratories
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Kraig Biocraft Laboratories generated cash of -$1,244,483, which is more than the previous year. Cash used in financing activities reached the amount of -$60,000 last year. Net change in cash is therefore -$1,310,882.
Cash Flow
| 2014 | -904.55K | -41.80K | 1.14M |
|---|---|---|---|
| 2015 | -967.56K | -39.28K | 750K |
| 2016 | -1.01M | -2.48K | 1.07M |
| 2017 | -729.54K | -31.16K | 480K |
| 2018 | -235.00K | -11.44K | 242K |
| 2019 | -1.08M | -100.79K | 1.3M |
| 2020 | -1.25M | 0 | 1.94M |
| 2021 | -1.80M | -547.37K | 3.88M |
| 2022 | -1.88M | -5.02K | 3.39M |
| 2023 | -1.24M | -6.39K | -60K |
KBLB Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 3.86M | 2.35M | 816.90K | 125.02K | 13.69K | 18.15K | 298.85K | 238.18K | 495.03K | 295.38K |
Operating activities | ||||||||||
Net income | -3.02M | -3.84M | -8.04M | -4.97M | -2.90M | -1.16M | -2.33M | -3.07M | -2.13M | -1.87M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 27.62K | 28.10K | 26.13K | 28.07K | 30.78K | 26.63K | 20.29K | 16.97K | 15.41K | 7.15K |
Stock-based compensation expense | 225K | 234.69K | 242.1K | 2.84M | 677.02K | 0 | 865 | 32.85K | 711 | 111.6K |
| Deferred income tax benefit | 225K | 234.69K | 242.1K | 2.84M | 677.02K | 0 | 865 | 32.85K | 711 | 111.6K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 25.87K | 5.98K | -31.85K | 0 | 0 |
Inventories | -304 | -6.58K | 0 | 0 | 0 | 5.19M | 3.98M | 2.91M | 0 | 0 |
Accounts payable | 1.29K | 138.15K | 199.72K | 39.05K | 314.36K | 136.32K | 164.59K | -16.42K | -28.75K | 194.31K |
Cash generated by operating activities | -1.24M | -1.88M | -1.80M | -1.25M | -1.08M | -235.00K | -729.54K | -1.01M | -967.56K | -904.55K |
Investing activities | ||||||||||
Purchases Of Investments | -2.58M | 0 | -450.21K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -6.39K | -5.02K | -97.15K | 0 | -100.79K | -11.44K | -31.16K | -2.48K | -39.28K | -41.80K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -6.39K | -5.02K | -547.37K | 0 | -100.79K | -11.44K | -31.16K | -2.48K | -39.28K | -41.80K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 739.86K | 266.33K | 17.49K | 1M | 1.07B | 450K | 1.02M | 750K | 1.15M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -60K | 2.66M | -50K | -40K | 300K | -242K | 30K | -50K | 0 | -3.98K |
Cash used in financing activities | -60K | 3.39M | 3.88M | 1.94M | 1.3M | 242K | 480K | 1.07M | 750K | 1.14M |
Net Change In Cash | -1.31M | 1.50M | 1.53M | 691.88K | 111.32K | -4.45K | -280.70K | 60.67K | -256.84K | 199.65K |
Cash at end of period | 2.55M | 3.86M | 2.35M | 816.90K | 125.02K | 13.69K | 18.15K | 298.85K | 238.18K | 495.03K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |